{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:33:44Z","timestamp":1780101224761,"version":"3.54.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.brainresbull.2022.10.013","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T12:01:59Z","timestamp":1666180919000},"page":"69-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Chronic agmatine treatment prevents olanzapine-induced obesity and metabolic dysregulation in female rats"],"prefix":"10.1016","volume":"191","author":[{"given":"Madhura P.","family":"Dixit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivkumar S.","family":"Sammeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrunali D.","family":"Dhokne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhada","family":"Mangrulkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj A.","family":"Upadhya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind J.","family":"Umekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh G.","family":"Taksande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandkishor R.","family":"Kotagale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.brainresbull.2022.10.013_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/oby.2006.6","article-title":"Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents","volume":"14","author":"Albaugh","year":"2006","journal-title":"Obesity"},{"issue":"8","key":"10.1016\/j.brainresbull.2022.10.013_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","article-title":"Pharmacokinetics and tissue distribution of olanzapine in rats","volume":"20","author":"Aravagiri","year":"1999","journal-title":"Biopharmaceut. Drug Dispos."},{"issue":"6","key":"10.1016\/j.brainresbull.2022.10.013_bib3","doi-asserted-by":"crossref","first-page":"C1411","DOI":"10.1152\/ajpcell.00529.2008","article-title":"The arginine metabolite agmatine protects mitochondrial function and confers resistance to cellular apoptosis","volume":"296","author":"Arndt","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"3","key":"10.1016\/j.brainresbull.2022.10.013_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1254\/jjp.69.285","article-title":"Selective inhibition of inducible nitric oxide synthase by agmatine","volume":"69","author":"Auguet","year":"1995","journal-title":"Jpn. J. Pharm."},{"issue":"1","key":"10.1016\/j.brainresbull.2022.10.013_bib5","doi-asserted-by":"crossref","first-page":"12669","DOI":"10.1038\/s41598-019-49078-0","article-title":"Safety and neurochemical profiles of acute and sub-chronic oral treatment with agmatine sulfate","volume":"9","author":"Bergin","year":"2019","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.brainresbull.2022.10.013_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163634","article-title":"Agmatine reduces lipopolysaccharide-mediated oxidant response via activating PI3K\/Akt pathway and up-regulating Nrf2 and HO-1 expression in macrophages","volume":"11","author":"Chai","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.brainresbull.2022.10.013_bib7","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/schbul\/sby058","article-title":"Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016","volume":"44","author":"Charlson","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.brainresbull.2022.10.013_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbr.2016.06.014","article-title":"Agmatine attenuates reserpine-induced oral dyskinesia in mice: role of oxidative stress, nitric oxide, and glutamate NMDA receptors","volume":"312","author":"Cunha","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"1\u20133","key":"10.1016\/j.brainresbull.2022.10.013_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.schres.2008.07.006","article-title":"Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study","volume":"105","author":"Daumit","year":"2008","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.10.013_bib10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ijo.2011.97","article-title":"The acute effects of olanzapine on ghrelin secretion, CCK sensitivity, meal size, locomotor activity and body temperature","volume":"36","author":"van der Zwaal","year":"2012","journal-title":"International journal of obesity (2005)"},{"issue":"1","key":"10.1016\/j.brainresbull.2022.10.013_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pbb.2010.05.029","article-title":"Olanzapine causes hypothermia, inactivity, a deranged feeding pattern and weight gain in female Wistar rats","volume":"97","author":"Evers","year":"2010","journal-title":"Pharm. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.brainresbull.2022.10.013_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.euroneuro.2003.12.001","article-title":"Effects of the classical antipsychotic haloperidol and atypical antipsychotic risperidone on weight gain, the oestrous cycle and uterine weight in female rats","volume":"14","author":"Fell","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.brainresbull.2022.10.013_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3103\/S0095452713040051","article-title":"Structural and quantitative changes of carbohydrate chain of erythrocyte membrane glycoproteins in experimental diabetes mellitus after treatment with agmatine","volume":"47","author":"Ferents","year":"2013","journal-title":"Cytol. Genet."},{"issue":"5","key":"10.1016\/j.brainresbull.2022.10.013_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0168-8278(03)00386-6","article-title":"Agmatine inhibits the proliferation of rat hepatoma cells by modulation of polyamine metabolism","volume":"39","author":"Gardini","year":"2003","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.10.013_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004995","article-title":"Fatty acid synthase cooperates with glyoxalase 1 to protect against sugar toxicity","volume":"11","author":"Garrido","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.brainresbull.2022.10.013_bib16","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00023210-200721110-00002","article-title":"Agmatine: metabolic pathway and spectrum of activity in brain","volume":"21","author":"Halaris","year":"2007","journal-title":"CNS Drugs"},{"issue":"7433","key":"10.1016\/j.brainresbull.2022.10.013_bib17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/493480c","article-title":"Obesity: multiple factors contribute","volume":"493","author":"Hamre","year":"2013","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.brainresbull.2022.10.013_bib18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.psyneuen.2008.01.018","article-title":"Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression","volume":"33","author":"Han","year":"2008","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.brainresbull.2022.10.013_bib19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/1871530315666150623092031","article-title":"Weight gain and metabolic changes during treatment with antipsychotics and antidepressants","volume":"15","author":"Himmerich","year":"2015","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"1\u20132","key":"10.1016\/j.brainresbull.2022.10.013_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0003-2670(02)00574-3","article-title":"The simple and rapid procedure for the determination of individual free fatty acids in serum","volume":"465","author":"Hu\u0161ek","year":"2002","journal-title":"Anal. Chim. Acta"},{"issue":"5","key":"10.1016\/j.brainresbull.2022.10.013_bib21","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4088\/JCP.v69n0503","article-title":"Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week randomized, double-blind, placebo-controlled trial","volume":"69","author":"Joffe","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.brainresbull.2022.10.013_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2004.01.011","article-title":"Activation of imidazoline receptor by agmatine to lower plasma glucose in streptozotocin-induced diabetic rats","volume":"358","author":"Jou","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"9618","key":"10.1016\/j.brainresbull.2022.10.013_bib23","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.brainresbull.2022.10.013_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-018-0116-8","article-title":"Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota","volume":"8","author":"Kao","year":"2018","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.brainresbull.2022.10.013_bib25","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/sj.bjp.0701969","article-title":"Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1\u2013selective antagonist BIBP3226","volume":"124","author":"Kask","year":"1998","journal-title":"Br. J. Pharm."},{"issue":"1\u20133","key":"10.1016\/j.brainresbull.2022.10.013_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejphar.2004.10.015","article-title":"Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat","volume":"505","author":"Kirk","year":"2004","journal-title":"Eur. J. Pharm."},{"issue":"1","key":"10.1016\/j.brainresbull.2022.10.013_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2005.07.019","article-title":"GABAA receptors mediate orexin-A induced stimulation of food intake","volume":"50","author":"Kokare","year":"2006","journal-title":"Neuropharmacology"},{"issue":"7358","key":"10.1016\/j.brainresbull.2022.10.013_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/bmj.325.7358.243","article-title":"Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study","volume":"325","author":"Koro","year":"2002","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.brainresbull.2022.10.013_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1385\/ENDO:29:1:91","article-title":"Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome","volume":"29","author":"Kusunoki","year":"2006","journal-title":"Endocrine"},{"issue":"7","key":"10.1016\/j.brainresbull.2022.10.013_bib30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/aje\/kwj289","article-title":"Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia","volume":"164","author":"Lambert","year":"2006","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.brainresbull.2022.10.013_bib31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1749-6632.1995.tb32418.x","article-title":"Agmatine is synthesized by a mitochondrial arginine decarboxylase in rat brain","volume":"763","author":"Li","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.brainresbull.2022.10.013_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1515\/CCLM.2001.006","article-title":"Determination of glycerol in plasma by an automated enzymatic spectrophotometric procedure","volume":"39","author":"Li","year":"2001","journal-title":"Clin. Chem. Lab. Med."},{"issue":"12","key":"10.1016\/j.brainresbull.2022.10.013_bib33","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"1\u20133","key":"10.1016\/j.brainresbull.2022.10.013_bib34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.schres.2008.05.011","article-title":"The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance","volume":"103","author":"Lykkegaard","year":"2008","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.brainresbull.2022.10.013_bib35","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1176\/ajp.2007.164.7.1050","article-title":"Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison","volume":"164","author":"McEvoy","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.brainresbull.2022.10.013_bib36","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1093\/clinchem\/24.12.2161","article-title":"The 4-hydroxybenzoate\/4-aminophenazone chromogenic system used in the enzymic determination of serum cholesterol","volume":"24","author":"Meiattini","year":"1978","journal-title":"Clin. Chem."},{"issue":"1\u20133","key":"10.1016\/j.brainresbull.2022.10.013_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.schres.2007.12.487","article-title":"Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1","volume":"101","author":"Meyer","year":"2008","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.brainresbull.2022.10.013_bib38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00213-006-0433-0","article-title":"A model for antipsychotic-induced obesity in the male rat","volume":"187","author":"Minet-Ringuet","year":"2006","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.brainresbull.2022.10.013_bib39","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/cncr.20407","article-title":"Intestinal tumor and agmatine (decarboxylated arginine) low content in colon carcinoma tissue specimens and inhibitory effect on tumor cell proliferation in vitro","volume":"101","author":"Molderings","year":"2004","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.brainresbull.2022.10.013_bib40","doi-asserted-by":"crossref","first-page":"9710","DOI":"10.1074\/jbc.M113.544726","article-title":"The molecular and metabolic influence of long term agmatine consumption","volume":"289","author":"Nissim","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.brainresbull.2022.10.013_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(97)01200-6","article-title":"Regional localization of agmatine in the rat brain: an immunocytochemical study","volume":"787","author":"Otake","year":"1998","journal-title":"Brain Res."},{"issue":"1\u20133","key":"10.1016\/j.brainresbull.2022.10.013_bib42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2006.09.009","article-title":"Elevation of systolic blood pressure in an animal model of olanzapine induced weight gain","volume":"551","author":"Patil","year":"2006","journal-title":"Eur. J. Pharm."},{"issue":"1","key":"10.1016\/j.brainresbull.2022.10.013_bib43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0091-3057(03)00042-X","article-title":"Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human","volume":"75","author":"Pouzet","year":"2003","journal-title":"Pharm. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.brainresbull.2022.10.013_bib44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-6147(00)01460-7","article-title":"Is agmatine a novel neurotransmitter in brain?","volume":"21","author":"Reis","year":"2000","journal-title":"Trends Pharm. Sci."},{"issue":"3","key":"10.1016\/j.brainresbull.2022.10.013_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0304-3940(98)00466-2","article-title":"Agmatine containing axon terminals in rat hippocampus form synapses on pyramidal cells","volume":"250","author":"Reis","year":"1998","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.brainresbull.2022.10.013_bib46","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1124\/jpet.105.086173","article-title":"Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse","volume":"314","author":"Roberts","year":"2005","journal-title":"J. Pharm. Exp. Ther."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.10.013_bib47","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3390\/nu12020576","article-title":"Evidence for dietary agmatine sulfate effectiveness in neuropathies associated with painful small fiber neuropathy. A pilot open-label consecutive case series study","volume":"12","author":"Rosenberg","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.brainresbull.2022.10.013_bib48","doi-asserted-by":"crossref","first-page":"bqz046","DOI":"10.1210\/endocr\/bqz046","article-title":"CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential","volume":"161","author":"Schlaepfer","year":"2020","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.brainresbull.2022.10.013_bib49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0006-2952(89)90044-0","article-title":"Stimulus-secretion coupling of arginine-induced insulin release. Insulinotropic action of agmatine","volume":"38","author":"Sener","year":"1989","journal-title":"Biochem. Pharm."},{"issue":"3","key":"10.1016\/j.brainresbull.2022.10.013_bib50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neulet.2009.03.093","article-title":"Activation of I2-imidazoline receptors by agmatine improved insulin sensitivity through two mechanisms in type-2 diabetic rats","volume":"457","author":"Su","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"2b","key":"10.1016\/j.brainresbull.2022.10.013_bib51","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1476-5381.2011.01484.x","article-title":"Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y","volume":"164","author":"Taksande","year":"2011","journal-title":"Br. J. Pharm."},{"issue":"9","key":"10.1016\/j.brainresbull.2022.10.013_bib52","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/sj.npp.1300460","article-title":"Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine inrodents","volume":"29","author":"Ugale","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.brainresbull.2022.10.013_bib53","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbr.2010.10.039","article-title":"Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats","volume":"217","author":"Weston-Green","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"19","key":"10.1016\/j.brainresbull.2022.10.013_bib54","doi-asserted-by":"crossref","first-page":"10688","DOI":"10.3390\/ijms221910688","article-title":"Inhibition of atherosclerosis and liver steatosis by agmatine in western diet-fed apoE-knockout mice is associated with decrease in hepatic de novo lipogenesis and reduction in plasma triglyceride\/high-density lipoprotein cholesterol ratio","volume":"22","author":"Wisniewska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.brainresbull.2022.10.013_bib55","first-page":"59","article-title":"Arginine nutrition in development, health and disease","volume":"3","author":"Wu","year":"2000","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"4","key":"10.1016\/j.brainresbull.2022.10.013_bib56","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MCA.0b013e328351ab2c","article-title":"How to interpret epicardial adipose tissue as a cause of coronary artery disease: a meta-analysis","volume":"23","author":"Xu","year":"2012","journal-title":"Coron. Artery Dis."},{"issue":"3","key":"10.1016\/j.brainresbull.2022.10.013_bib57","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.phrs.2007.05.007","article-title":"Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells","volume":"56","author":"Yang","year":"2007","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.brainresbull.2022.10.013_bib58","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0022-3565(24)37988-1","article-title":"Agmatine selectively blocks then-methyl-d-aspartate subclass of glutamate receptor channels in rat hippocampal neurons","volume":"288","author":"Yang","year":"1999","journal-title":"J. Pharm. Exp. Ther."},{"issue":"6550","key":"10.1016\/j.brainresbull.2022.10.013_bib59","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1126\/science.abh3556","article-title":"Finding genes that control body weight","volume":"373","author":"Yeo","year":"2021","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.brainresbull.2022.10.013_bib60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0003-2670(02)00777-8","article-title":"Quantitation of agmatine by liquid chromatography with laser-induced fluorescence detection","volume":"470","author":"Zhao","year":"2002","journal-title":"Anal. Chim. Acta"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923022002830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923022002830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:51:22Z","timestamp":1759783882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923022002830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":60,"alternative-id":["S0361923022002830"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2022.10.013","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic agmatine treatment prevents olanzapine-induced obesity and metabolic dysregulation in female rats","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2022.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}